Detalhe da pesquisa
1.
Safety and activity of anti-mesothelin antibody-drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian cancer: multicenter, phase Ib dose escalation and expansion study.
Int J Gynecol Cancer;
33(4): 562-570, 2023 04 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36564099
2.
Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial.
Lancet Oncol;
23(4): 540-552, 2022 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35358455
3.
Treatment with the PARP inhibitor, niraparib, sensitizes colorectal cancer cell lines to irinotecan regardless of MSI/MSS status.
Cancer Cell Int;
15(1): 14, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25685067
4.
The ligand binding domain controls glucocorticoid receptor dynamics independent of ligand release.
Mol Cell Biol;
27(7): 2442-51, 2007 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17261597
5.
Ligand-specific dynamics of the androgen receptor at its response element in living cells.
Mol Cell Biol;
27(5): 1823-43, 2007 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17189428
6.
First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody-Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors.
J Clin Oncol;
38(16): 1824-1835, 2020 06 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32213105
7.
Evaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM).
J Patient Rep Outcomes;
3(1): 34, 2019 Jun 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31209661
8.
Induction of apoptosis in human prostate cancer cells by insulin-like growth factor binding protein-3 does not require binding to retinoid X receptor-alpha.
Endocrinology;
149(4): 1802-12, 2008 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18162523
9.
Protein dynamics in the nuclear compartment.
Curr Opin Genet Dev;
12(2): 137-41, 2002 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-11893485
10.
Ligand-specific dynamics of the progesterone receptor in living cells and during chromatin remodeling in vitro.
Mol Cell Biol;
25(6): 2406-18, 2005 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15743833
11.
Targeting mesothelin in cancer.
Mol Ther Oncolytics;
31: 100756, 2023 Dec 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38075245
12.
Anetumab ravtansine inhibits tumor growth and shows additive effect in combination with targeted agents and chemotherapy in mesothelin-expressing human ovarian cancer models.
Oncotarget;
9(75): 34103-34121, 2018 Sep 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30344925
13.
Global nature of dynamic protein-chromatin interactions in vivo: three-dimensional genome scanning and dynamic interaction networks of chromatin proteins.
Mol Cell Biol;
24(14): 6393-402, 2004 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15226439
14.
Recruitment of dioxin receptor to active transcription sites.
Mol Biol Cell;
13(6): 2001-15, 2002 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12058065
15.
Molecular cloning and characterization of STAMP2, an androgen-regulated six transmembrane protein that is overexpressed in prostate cancer.
Oncogene;
24(31): 4934-45, 2005 Jul 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15897894
16.
Kallikrein 4 is a predominantly nuclear protein and is overexpressed in prostate cancer.
Cancer Res;
64(7): 2365-70, 2004 Apr 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15059887
17.
Turkish Ministry of Health, 2nd Turkish Medical General Assembly Clinical Oncology Study Group Report.
J Breast Health;
12(1): 9-17, 2016 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28331725
18.
Phosphorylation of p53 at serine 37 is important for transcriptional activity and regulation in response to DNA damage.
Oncogene;
23(1): 49-57, 2004 Jan 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-14712210
19.
Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins.
Oncogene;
23(25): 4400-12, 2004 May 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15077192
20.
A novel in situ assay for the identification and characterization of soluble nuclear mobility factors.
Sci STKE;
2004(238): pl10, 2004 Jun 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15213337